Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Michael Wachs to Retrospective Studies

This is a "connection" page, showing publications Michael Wachs has written about Retrospective Studies.

 
Connection Strength
  
 
 
0.273
  
  1. Chirichella TJ, Dunham CM, Zimmerman MA, Phelan EM, Mandell MS, Conzen KD, Kelley SE, Nydam TL, Bak TE, Kam I, Wachs ME. Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy. World J Gastroenterol. 2016 Mar 28; 22(12):3392-403.
    View in: PubMed
    Score: 0.042
  2. Bauer J, Johnson S, Durham J, Ludkowski M, Trotter J, Bak T, Wachs M. The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl. 2006 Oct; 12(10):1544-51.
    View in: PubMed
    Score: 0.022
  3. Rolfes PS, Yoeli D, Feldman AG, Adams MA, Wachs ME, Boster JM. Modern-era successful liver transplantation outcomes in children with hepatic undifferentiated embryonal sarcoma. Pediatr Transplant. 2024 Feb; 28(1):e14645.
    View in: PubMed
    Score: 0.018
  4. Ziogas IA, Schmoke N, Yoeli D, Cullen JM, Boster JM, Wachs ME, Adams MA. The effect of donor graft type on survival after liver transplantation for hepatoblastoma in children. Pediatr Transplant. 2024 Feb; 28(1):e14641.
    View in: PubMed
    Score: 0.018
  5. Yoeli D, Feldman AG, Choudhury RA, Moore HB, Sundaram SS, Nydam TL, Wachs ME, Pomfret EA, Adams MA, Jackson WE. Can non-directed living liver donation help improve access to grafts and correct socioeconomic disparities in pediatric liver transplantation? Pediatr Transplant. 2023 03; 27(2):e14428.
    View in: PubMed
    Score: 0.017
  6. Blanchette E, Pahlavan S, Yoeli D, Brigham D, Sater A, Wachs M, Bock M, Adams M. Successful use of intra-operative continuous renal replacement therapy in pediatric liver transplant recipients: Single center case series. Pediatr Transplant. 2022 12; 26(8):e14377.
    View in: PubMed
    Score: 0.016
  7. Yoeli D, Nguyen T, Wilder M, Huang J, Pahlavan S, Brigham D, Sundaram SS, Wachs ME, Adams MA. Immediate extubation following pediatric liver transplantation. Pediatr Transplant. 2022 12; 26(8):e14352.
    View in: PubMed
    Score: 0.016
  8. Yoeli D, Choudhury RA, Moore HB, Jackson WE, Nydam TL, Wachs ME, Pomfret EA, Adams MA. Living Donor Liver Transplant Center Volume Influences Waiting List Survival Among Children Listed for Liver Transplantation. Transplantation. 2022 09 01; 106(9):1807-1813.
    View in: PubMed
    Score: 0.016
  9. Yoeli D, Choudhury RA, Sundaram SS, Mack CL, Roach JP, Karrer FM, Wachs ME, Adams MA. Primary vs. salvage liver transplantation for biliary atresia: A retrospective cohort study. J Pediatr Surg. 2022 Oct; 57(10):407-413.
    View in: PubMed
    Score: 0.016
  10. Yoeli D, Choudhury RA, Nydam TL, Pomposelli JJ, Goss JA, Pomfret EA, Wachs ME, Adams MA. The Surge in Deceased Liver Donors Due to the Opioid Epidemic: Is It Time to Split the Difference? Transplantation. 2021 10 01; 105(10):2239-2244.
    View in: PubMed
    Score: 0.015
  11. Yoeli D, Jackson WE, Adams MA, Wachs ME, Sundaram SS, Sater A, Cisek JR, Choudhury RA, Nydam TL, Pomposelli JJ, Conzen KD, Kriss MS, Burton JR, Pomfret EA. Challenging the Traditional Paradigm of Supply and Demand in Pediatric Liver Transplantation Through Nondirected Living Donation: A Case Series. Liver Transpl. 2021 10; 27(10):1392-1400.
    View in: PubMed
    Score: 0.015
  12. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F, et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation. 1995 Jan 27; 59(2):230-4.
    View in: PubMed
    Score: 0.010
  13. Zimmerman MA, Kelly MA, Campsen J, Mandell MS, Wachs M, Bak T, Skibba A, Lancaster B, Kam I. The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation. Clin Transplant. 2010 Jul-Aug; 24(4):E103-8.
    View in: PubMed
    Score: 0.007
  14. Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Skibba A, Kam I. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver Transpl. 2008 May; 14(5):633-8.
    View in: PubMed
    Score: 0.006
  15. Campsen J, Hendrickson RJ, Zimmerman MA, Wachs M, Bak T, Russ P, Bennet W, Trotter J, Kam I. Adult right lobe live donor liver transplantation without reconstruction of the middle hepatic vein: a single-center study of 109 cases. Transplantation. 2008 Mar 15; 85(5):775-7.
    View in: PubMed
    Score: 0.006
  16. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kam I. Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course. Liver Transpl. 2008 Feb; 14(2):181-5.
    View in: PubMed
    Score: 0.006
  17. Hayashi PH, Trotter JF, Forman L, Kugelmas M, Steinberg T, Russ P, Wachs M, Bak T, Kam I, Everson GT. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Liver Transpl. 2004 Jan; 10(1):42-8.
    View in: PubMed
    Score: 0.004
  18. Kugelmas M, Osgood MJ, Trotter JF, Bak T, Wachs M, Forman L, Kam I, Everson GT. Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection. Liver Transpl. 2003 Nov; 9(11):1159-65.
    View in: PubMed
    Score: 0.004
  19. Kugelmas M, Spiegelman P, Osgood MJ, Young DA, Trotter JF, Steinberg T, Wachs ME, Bak T, Kam I, Everson GT. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 2003 Jul; 9(7):727-32.
    View in: PubMed
    Score: 0.004
  20. Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl. 2003 Jul; 9(7):737-40.
    View in: PubMed
    Score: 0.004
  21. Wiseman AC, Kam I, Christians U, Jani A, Bak T, Wachs M, Chan L. Fixed-dose sirolimus with reduced dose calcineurin inhibitor: the University of Colorado experience. Transplant Proc. 2003 May; 35(3 Suppl):122S-124S.
    View in: PubMed
    Score: 0.004
  22. Trotter JF, Wachs ME, Trouillot TE, Bak T, Kugelmas M, Kam I, Everson G. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus. Liver Transpl. 2001 May; 7(5):401-8.
    View in: PubMed
    Score: 0.004
  23. Emond J, Wachs ME, Renz JF, Kelley S, Harris H, Roberts JP, Ascher NL, Lim RC. Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma. Arch Surg. 1995 Aug; 130(8):824-30; discussion 830-1.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)